Skip to content

Analysis of Clinical Factors for Panvascular Diseases Based on Bayesian Network Model

Analysis of Clinical Factors for Panvascular Diseases Based on Bayesian Network Model

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001060
Enrollment
Unknown
Registered
2026-04-24
Start date
2026-05-01
Completion date
Unknown
Last updated
2026-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panvascular disease

Interventions

Panvascular Disease Group:None
Non-panvascular disease group:None

Sponsors

Xiyuan Hospital of China Academy of Chinese Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 119 Years

Inclusion criteria

Inclusion criteria: Vascular Disease Group: (1) Patients with at least one of the following admission diagnoses: coronary artery disease, intracranial arteriosclerosis, carotid arteriosclerosis, or lower extremity arteriosclerosis; (2) Age = 18 years; (3) Patients with complete data from coronary artery CTA or angiography, cranial MRI or DSA, carotid ultrasound, and lower extremity ultrasound. Non-vascular Disease Patients: (1) Patients whose discharge diagnosis does not include atherosclerotic diseases; (2) Age = 18 years; (3) Patients with complete data from coronary artery CTA or angiography, cranial MRI or DSA, carotid ultrasound, and lower extremity ultrasound.

Exclusion criteria

Exclusion criteria: (1) Pregnant and breastfeeding women; (2) Patients with acute or chronic infectious diseases; (3) Patients with malignant tumors; (4) Patients with anemia or hematological disorders; (5) Patients with immunological disorders; (6) Patients with severe liver or kidney dysfunction; (7) Patients who explicitly state that their medical records are not to be used for research.

Design outcomes

Primary

MeasureTime frame
Total Cholesterol;Triglyceride;Low-density lipoprotein cholesterol;High-density lipoprotein cholesterol;

Secondary

MeasureTime frame
Lipoprotein(a);Fasting Blood Glucose;glycated hemoglobin;Uric acid;creatinine;Urea nitrogen;N-terminal pro-B-type natriuretic peptide;Homocysteine;Cystatin C;Platelet Count;D-dimer;Prothrombin Time;Activated Partial Thromboplastin Time;Thrombin Clotting Time;Fibrinogen;White blood cell count;Neutrophil count;High-sensitivity C-reactive protein;Procalcitonin;Interleukin-6;Tumor Necrosis Factor-alpha;Body Mass Index;

Countries

China

Contacts

Public ContactMa Xiaojuan

Xiyuan Hospital of China Academy of Chinese Medical Sciences

abc_mxj@aliyun.com13466687265

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: May 1, 2026